Feedback
We would very much appreciate any thoughts you may have about OpenCME and how it could be made more useful for physicians like you.
Clinical Assistant Professor
Department of Community Health and Family Medicine
University of Florida College of Medicine
Gainesville, Florida
Professor of Medicine
Division of Gerontology and Geriatric Medicine
University of Washington School of Medicine
Associate Director, Clinical Affairs
Geriatric Research, Education and Clinical Center
Director, Clinical Research Unit
VA Puget Sound Health Care System
Seattle, Washington
Clinical Associate Professor of Family Medicine and Urology
The Warren Alpert Medical School of Brown University
Co-Director, Men’s Health Center
Chief of Family and Community Medicine
Miriam Hospital
Providence, Rhode Island
Associate Professor
Family Medicine
State University of New York
Downstate Medical Center
Brooklyn, New York

Professor
Department of Pharmacy Practice
Director, Continuing Professional Education
Purdue University College of Pharmacy
West Lafayette, Indiana
| Release Date: | September 29, 2011 |
| Expiration Date: | September 29, 2012 |
| Credit Types: | CME |
| Credit Amount: | 1.5 Credits |
| Estimated Time for Completion: | 90 minutes |
| Registration Required: | No |
| Cost: | Free |
Purdue University College of Pharmacy
This activity is intended for primary care physicians and other health care providers who treat patients with MHG.
There are no prerequisites for this educational activity.
Guided by comprehensive assessment of clinical knowledge gaps and needs, this educational activity is intended to improve the assessment, recognition, treatment, and ongoing management of patients with MHG.
At the conclusion of this program, participants should be better prepared to:
MHG is an endocrine pathology characterized by testosterone deficiency. The cause can be either testicular (primary MHG), pituitary-hypothalamic (secondary MHG), or geriatric.1 A 2007 survey of 1,475 men aged 30 to 79 years reported a prevalence of 5.6% for symptomatic androgen deficiency and a projected increase of 17% in MHG risk with every 10-year increase in age.2 A year earlier, the Hypogonadism In Males (HIM) study demonstrated an MHG prevalence of about 40% in American men 45 years or older.3 As the US population ages, MHG prevalence is expected to reach 6.5 million by 2025.2
Despite the significant burden of MHG on patients and their families, this condition continues to be underreported and undertreated. Primary care physicians in particular face a broad array of diagnostic and therapeutic challenges for which cutting-edge insights into evidence-based best practices are needed—and are key to improved patient outcomes. This educational program and interactive forum are designed to enhance clinician understanding of this complex disorder using expert insights into differential diagnosis, clinical profile, and current therapeutic options.
References
1. Nieschlag E, et al. J Androl. 2006;27:135-137.
2. Araujo AB, et al. J Clin Endocrinol Metab. 2007;92:4241-4247.
3. Mulligan T, et al. Int J Clin Pract. 2006;60:762-769
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Purdue University College of Pharmacy and Asante Communications, LLC. Purdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the ACCME to provide continuing medical education for physicians.
Purdue University College of Pharmacy designates this enduring material for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Supported by an educational grant from Lilly USA, LLC.
The presenting faculty reported the following:
Louis Kuritzky, MD, Abbott Laboratories (Advisory Board, Honorarium); Endo Pharmaceuticals (Advisory Board, Honorarium).
Alvin M. Matsumoto, MD, Abbott Laboratories (Grants/Research Support, Consultant/Speakers Bureau); BHR Pharma, LLC (Grants/Research Support); Endo Pharmaceuticals (Consultant/Speakers Bureau); GlaxoSmithKline plc (Grants/Research Support); Trimel BioPharma SRL (Consultant/Speakers Bureau).
Martin M. Miner, MD, Abbott Laboratories (Advisory Board); Atria BPH, Inc. (Consultant); Auxilium Pharmaceuticals, Inc. (Advisory Board); Endo Pharmaceuticals (Advisory Board); GlaxoSmithKline plc (Grants/Research Support).
Richard Sadovsky, MD, Abbott Laboratories (Advisory Board, Consultant/Speakers Bureau); Endo Pharmaceuticals (Advisory Board, Consultant/Speakers Bureau, Honorarium); Lilly USA, LLC (Advisory Board, Consultant/Speakers Bureau).
Robert W. Bennett, MS, RPh (CME Reviewer), has no relevant financial relationships to disclose.
All additional planning committee members, Asante Communications, LLC, staff and Purdue University College of Pharmacy staff have no financial relationships to disclose.
The opinions, ideas, recommendations, and perspectives expressed in this program are those of the program authors and presenting faculty only and do not necessarily reflect the opinions, ideas, recommendations, or perspective of their affiliated institutions, Purdue University College of Pharmacy, Asante Communications, or the activity’s commercial supporters.
Presenting faculty do not to discuss off-label usage of a commercial product in his presentation.
There are no fees for participating in and receiving credit for this activity. Participants must read the objectives and enduring material, and answer the multiple-choice posttest. Please complete the evaluation form, which enables you to comment on the quality of the instructional process, the perception of enhanced professional effectiveness and commercial bias, and express your views on future educational needs. Credit is available through September 29, 2012.
Please be ready to print your certificate at this time.
Contact Information for Questions about the Activity
Chrys Marzan, cmarzan@asanteglobal.com
All faculty and staff involved in the planning or presentation of continuing education activities sponsored/provided by Purdue University College of Pharmacy are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity.
© 2011 Purdue University College of Pharmacy and Asante Communications. All rights reserved. No part of this activity may be used or reproduced in any manner whatsoever without written permission, except in the case of brief quotations embodied in articles or reviews.

"OpenCME has initially been made available in a "beta" edition with minimal content, functionality and online presence. Our editorial team is working hard to add many other specialty areas to the list above."
Which of the following measures is diagnostic in a patient with male hypogonadism?
Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.
Please use the form below if you would like to offer your website visitors high quality CME content by adding the OpenCME Widget to one or more of your pages.